4D pharma plc (LBPS) Social Stream
4D Pharma PLC (LBPS) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering LBPS.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
LBPS Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for LBPS as an investment opportunity.
- In the context of stocks in the mid market cap category, 4D Pharma PLC's upside potential (average analyst target price relative to current price) is greater than 99.72% of them.
- In terms of how 4D Pharma PLC fares relative to stocks in the mid market cap category, note that its number of analysts covering the stock is higher than 3.31% of that group.
- In terms of how 4D Pharma PLC fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than 88.19% of that group.
- LBPS has a higher average analyst price target than 59.58% of Pharmaceutical Products stocks.
Is LBPS a Buy, Hold or Sell? See the POWR Ratings now!